Interview with Diana Valencia, Executive Director, LatAm Clinical Trials
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Address: Av. 9 No. 123-86 / Of. 703 Bogotá D.C. Colombia
Tel: (571) 6203530
Web: http://www.latamtrials.com/
Latam Clinical Trials specializes in conducting superior Phase I-IV clinical trials in Latin America, specifically in the Andean Region, Central America and the Caribbean, offering our three services lines: Conducting and Monitoring Clinical trials, Management of Regulatory Issues, and training.
Latam Clinical Trials has business development offices in the USA and clinical staff located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Ecuador, Colombia, Peru, Panama and Venezuela.
Latam Clinical Trials’ geographic reach is extended to additional countries in Latin America through partnerships with other local CROs in Mexico, Argentina and Brazil
Regulatory Support and Submission, Patient Recruitment Management, Project Management
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Medical devices are one of the most profitable niches in Colombian health. Marisol Sanchez, president of the Camara de Proveedores de Salud, notes that “the medical device sector correlated to…
President Santos appointed economist Alejandro Gaviria as the new Minister of Health and Social Protection in September 2012. Gaviria’s priority has been to create health reform that would introduce…
Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the…
Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market and its hopes and intentions for the future. One of the main…
Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The…
As a means of introduction, could you describe your background and how you became involved with Nutripharma in the first place? Nutripharma is a 12-year-old family company created by my…
Can you trace the evolution of the Colombian economy over the last few years? The Colombian economy is experiencing a time of significant growth with production and investment projects as…
Sr. Gutierrez, when we interviewed your father in 2010, he described to us the strong potential of the medical industry in Colombia in the future. Since that time, would you…
What is your background, and how did you become involved with Grupo Amarey? My first job in the medical industry was with Johnson & Johnson Medical, which back then was…
In our last meeting, you said that you were looking forward to a decade of continuous growth and to be the number one partner of choice for patients, physicians, governments…
The operations and sales managers of Cegedim Colombia discuss the impact of healthcare reform on the Colombian pharma market, partnering opportunities in the…
You have an extensive background in the healthcare sector, with positions in Colciencias, the Department of Public Health, and the National University of Colombia. What can you bring from these…
See our Cookie Privacy Policy Here
